Knowledge Center: Article

How to bridge efficacy data from a few products to a biocidal product family

Application note:
Chemical Watch dated 21 January 2020 by Stan de Groot | expert in Registration Services & Risk Assessment

A huge effort is required on the part of an applicant to conduct efficacy studies for all members of a biocidal product family.

Get in touch with us: